Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
Submitted by
admin
on October 30, 2008 - 11:04am
Source:
Yahoo/AP
Headline:
GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
Do Not Allow Advertisers to Use My Personal information
